With respect to dosage, the average reductions were: 2000 mcg: 71.5% (single data point) 1,000 mcg: 31.8% Although limited data are available for higher dosages, the findings support the efficacy of both oral and non-oral B12 formulations in modulating homocysteine levels
Macrophages as a therapeutic target in metastatic prostate cancer: a way to overcome immunotherapy resistance
[4] Ongoing and future trials are investigating their long-term efficacy and safety profiles, with a focus on cost, patient adherence, and side effects
Less common but serious side effects include severe allergic reactions, hypokalemia (low potassium), fluid retention, and heart failure in patients with pre-existing cardiac conditions
In those cases, GLP-1 based therapies like tirzepatide and semaglutide offer clear advantages over SGLT2 inhibitors regarding urinary infection risk